Description
Tipol is a new type of therapeutic drug. It is the world's first and currently the only once-weekly glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 receptor agonist approved for type 2 diabetes.
- Semaglutide
 - telpotide
 - canagliflozin
 - retatreotide
 - API
 - peptide
 
Production Capacity:
Not informed
Delivery Timeframe:
Immediate
Incoterms:
Not informedPackaging Details:
Not informed
More about 
 Senova Technology
    100-200
Employees
1M - 2M
Sales volume (USD)
100%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
 
Keywords
- Semaglutide
 - tirpatide
 - ritatreotide
 - canglitide
 
Contact and location
- 
                    
Henry ********
 - 
                    
+86 1********
 - 
                    
Shenzhen / | China